Literature DB >> 7081082

Polymorphous ventricular tachycardia associated with normal and long Q-T intervals.

J Soffer, L S Dreifus, E L Michelson.   

Abstract

Polymorphous ventricular tachycardia may occur in the setting of either a normal or a prolonged Q-T interval. Torsade de pointes is a form of polymorphous ventricular tachycardia in which the polarity of the QRS complex exhibits phasic alterations in both axis and rate. Traditionally, torsade de pointes has been described in association with a variety of congenital and acquired (including drug and metabolic) causes of Q-T prolongation. The distinction between torsade de pointes and those polymorphous ventricular tachycardias occurring in patients with a normal Q-T interval has important therapeutic implications. The former requires strict avoidance of all drugs that may potentially further delay repolarization, including class I antiarrhythmic agents; immediately, the initiation of cardiac pacing is often necessary for control of arrhythmia, and on a long-term basis, sympathetic nervous blockade is often efficacious. In contrast, the polymorphous ventricular tachycardias with a normal Q-T interval usually respond to conventional therapy, including administration of class I antiarrhythmic agents. Thus, the management of polymorphous ventricular tachycardia should be based on the presence of absence of associated repolarization rather than on the morphologic features of the tachycardia. Unfortunately, recent advances in basic and clinical electrophysiology have not yet elucidated the pathophysiologic basis for these arrhythmias, although this is an area of active investigative interest.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7081082     DOI: 10.1016/0002-9149(82)90224-7

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  14 in total

Review 1.  Pharmacokinetic factors in the adverse cardiovascular effects of antipsychotic drugs.

Authors:  Candace S Brown; Richard G Farmer; Judith E Soberman; Samantha F Eichner
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

2.  Self-terminating polymorphous ventricular tachycardia occurring at the peak of myocardial ischemia.

Authors:  Jonathan Buber; Hanoch Hod; Shlomi Matetzky
Journal:  Ann Noninvasive Electrocardiol       Date:  2011-10       Impact factor: 1.468

3.  Prolongation of the QT interval by ketanserin.

Authors:  H A Cameron; P C Waller; L E Ramsay
Journal:  Postgrad Med J       Date:  1988-02       Impact factor: 2.401

4.  The prolonged QT interval--a frequently unrecognized abnormality.

Authors:  R A Kenny; R Sutton
Journal:  Postgrad Med J       Date:  1985-05       Impact factor: 2.401

5.  Acute and chronic ketanserin in essential hypertension: antihypertensive mechanisms and pharmacokinetics.

Authors:  R Donnelly; H L Elliott; P A Meredith; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1987-11       Impact factor: 4.335

6.  Monophasic action potentials in a patient with multiform ventricular tachycardia without QT prolongation.

Authors:  T Emori; T Ohe; K Shimomura
Journal:  Br Heart J       Date:  1993-04

7.  A unitary mechanism of calcium antagonist drug action.

Authors:  K M Murphy; R J Gould; B L Largent; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

8.  Polymorphous ventricular tachycardia following cardiopulmonary bypass.

Authors:  L D Thompson; A J Cohen; R M Bellasis
Journal:  J Natl Med Assoc       Date:  1996-01       Impact factor: 1.798

9.  Cardiac arrhythmias in subarachnoid haemorrhage.

Authors:  T Stober; T Anstätt; S Sen; K Schimrigk; H Jäger
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

10.  Sotalol, hypokalaemia, syncope, and torsade de pointes.

Authors:  J K McKibbin; W A Pocock; J B Barlow; R N Millar; I W Obel
Journal:  Br Heart J       Date:  1984-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.